Ergo Bioscience

Ergo Bioscience

Private
SunchalesHealthcare & Life Scienceshttps://ergobiotech.com

Last Round

Seed

Oct 17, 2024

Total Funding Raised

$2.5M

Company Overview

Ergo Bioscience is a food products company that develops plant-based protein ingredients designed to create more realistic plant-based meat and dairy alternatives.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Sustainable Materials, Advanced Materials, Clean Manufacturing

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

animal-free ingredientsprecision fermentationplant cell fermentationalternative proteinsalt proteincellular agricultureanimal-free myoglobinanimal-free caseinmolecular farmingB2B ingredientsplant-based meatplant-based dairyfood techbiomanufacturingEUKARYA platformingredient developmenthigh-value metabolitescell line licensing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Ergo Bioscience Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Ergo Bioscience Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
SeedOct 17, 2024
GrantSep 19, 2023

Key People

Founding team and executive leadership

Augusto Desuque

Chief Technology Officer (CTO) Head Of Bioprocessing Co-founder, Chief Technology Officer (CTO) Head Of Bioprocessing Co-founder

Founding Team

Ergo Bioscience Investors

Notable investors and investment history

Ergo Bioscience Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Ergo Bioscience Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Ergo Bioscience's valuation, stock price, and market status.

Firmographic Details

HeadquartersSunchales
Employee Range24
Year Founded2020
Last FundingOct 17, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.